BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37421166)

  • 1. Trends in participant race and sex reporting in lung cancer phase III clinical trials.
    Aslam FN; Manochakian R; Lou Y; Colon-Otero G; Sher T
    Cancer Rep (Hoboken); 2023 Sep; 6 Suppl 1(Suppl 1):e1856. PubMed ID: 37421166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials.
    Chen MS; Lara PN; Dang JH; Paterniti DA; Kelly K
    Cancer; 2014 Apr; 120 Suppl 7(0 7):1091-6. PubMed ID: 24643646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reporting of Participant Race and Ethnicity in Published US Pediatric Clinical Trials From 2011 to 2020.
    Rees CA; Stewart AM; Mehta S; Avakame E; Jackson J; McKay J; Portillo EN; Michelson KA; Duggan CP; Fleegler EW
    JAMA Pediatr; 2022 May; 176(5):e220142. PubMed ID: 35311946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials: A Systematic Review and Meta-analysis.
    Allison K; Patel DG; Greene L
    JAMA Netw Open; 2021 May; 4(5):e218348. PubMed ID: 34003274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials.
    Javier-DesLoges J; Nelson TJ; Murphy JD; McKay RR; Pan E; Parsons JK; Kane CJ; Kader AK; Derweesh IH; Nodora J; Patel SP; Martinez ME; Rose BS
    Cancer; 2022 Feb; 128(4):770-777. PubMed ID: 34806168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minority Representation in Migraine Treatment Trials.
    Robbins NM; Bernat JL
    Headache; 2017 Mar; 57(3):525-533. PubMed ID: 28127754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race, ethnicity, and gender reporting in North American clinical trials for BCG-unresponsive non-muscle invasive bladder cancer.
    Fletcher SA; Bivalacqua TJ; Brawley OW; Kates M
    Urol Oncol; 2022 May; 40(5):195.e13-195.e18. PubMed ID: 34949513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do Current Lung Cancer Clinical Trials Represent All Patient Populations Including Minorities?
    Nemala A; Ullah A; Yacur M; Karim NA
    Clin Lung Cancer; 2023 Nov; 24(7):573-580. PubMed ID: 37574437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012.
    Pang HH; Wang X; Stinchcombe TE; Wong ML; Cheng P; Ganti AK; Sargent DJ; Zhang Y; Hu C; Mandrekar SJ; Redman MW; Manola JB; Schilsky RL; Cohen HJ; Bradley JD; Adjei AA; Gandara D; Ramalingam SS; Vokes EE
    J Clin Oncol; 2016 Nov; 34(33):3992-3999. PubMed ID: 27646951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities in Representation of Women, Older Adults, and Racial/Ethnic Minorities in Immune Checkpoint Inhibitor Trials.
    Riaz IB; Islam M; Khan AM; Naqvi SAA; Siddiqi R; Khakwani KZR; Asghar N; Ikram W; Hussain SA; Singh P; Warner JL; Sonpavde GP; Odedina FT; Kehl KL; Duma N; Bryce AH
    Am J Med; 2022 Aug; 135(8):984-992.e6. PubMed ID: 35483426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation in cancer clinical trials: race-, sex-, and age-based disparities.
    Murthy VH; Krumholz HM; Gross CP
    JAMA; 2004 Jun; 291(22):2720-6. PubMed ID: 15187053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recruiting intergenerational African American males for biomedical research Studies: a major research challenge.
    Byrd GS; Edwards CL; Kelkar VA; Phillips RG; Byrd JR; Pim-Pong DS; Starks TD; Taylor AL; Mckinley RE; Li YJ; Pericak-Vance M
    J Natl Med Assoc; 2011 Jun; 103(6):480-7. PubMed ID: 21830630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An examination of the influence of patient race and ethnicity on expressed interest in learning about cancer clinical trials.
    Markman M; Petersen J; Montgomery R
    J Cancer Res Clin Oncol; 2008 Jan; 134(1):115-8. PubMed ID: 17598129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporting of Study Participant Demographic Characteristics and Demographic Representation in Premarketing and Postmarketing Studies of Novel Cancer Therapeutics.
    Varma T; Wallach JD; Miller JE; Schnabel D; Skydel JJ; Zhang AD; Dinan MA; Ross JS; Gross CP
    JAMA Netw Open; 2021 Apr; 4(4):e217063. PubMed ID: 33877309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participation of Patients From Racial and Ethnic Minority Groups in Phase 1 Early Cancer Drug Development Trials in the US, 2000-2018.
    Dunlop H; Fitzpatrick E; Kurti K; Deeb S; Gillespie EF; Dover L; Yerramilli D; Gomez SL; Chino F; Tsai CJ
    JAMA Netw Open; 2022 Nov; 5(11):e2239884. PubMed ID: 36326764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018.
    Loree JM; Anand S; Dasari A; Unger JM; Gothwal A; Ellis LM; Varadhachary G; Kopetz S; Overman MJ; Raghav K
    JAMA Oncol; 2019 Oct; 5(10):e191870. PubMed ID: 31415071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of inclusion of black participants in neuropsychological studies: A scoping review and call to action.
    Ray CGL; Hudson Mariouw K; Anderson KM; George E; Bisignano N; Hernandez S; Montgomery VL
    Clin Neuropsychol; 2022 Feb; 36(2):227-244. PubMed ID: 35001854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparities in US Lung Cancer Clinical Trial Enrollment.
    Kilic S; Zhao J; Okut H; Jani CT; Radwan A; Dudipala H; Burns L; Tapan U
    J Racial Ethn Health Disparities; 2023 Aug; ():. PubMed ID: 37651069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
    Albain KS; Unger JM; Crowley JJ; Coltman CA; Hershman DL
    J Natl Cancer Inst; 2009 Jul; 101(14):984-92. PubMed ID: 19584328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.